UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000008611
Receipt number R000010124
Scientific Title A single-center open-label parallel-group study on the efficacy and the safety of survivin-2B peptide vaccine therapy for patients with advanced or recurrent digestive organ cancer, for which there is no effective treatment.
Date of disclosure of the study information 2012/08/03
Last modified on 2014/04/14 15:31:53

No. Disposal Last modified on Item of update
1 Insert 2012/08/03 20:53:37
2 Update 2012/08/27 14:24:18 Acronym
Acronym
3 Update 2012/09/06 13:45:03 Recruitment status
4 Update 2013/02/14 17:31:29 Last follow-up date
5 Update 2014/04/14 11:53:00 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
6 Update 2014/04/14 15:31:53 Recruitment status